- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02161263
Quality of Vision and Quality of Life With LASIK
March 17, 2024 updated by: Edward E. Manche
Patient Quality of Vision and Quality of Life With LASIK Surgery
The investigators are administering a validated questionnaire looking at patient reported quality of life and quality of vision after LASIK surgery
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The purpose of the study is to evaluate the prevalence of any functional limitations and their associated factors at one, three, six, and twelve months after LASIK surgery and finally the level of patient satisfaction, including the prevalence of any dissatisfaction and its associated factors at one, three, six and twelve months following LASIK surgery using two questionnaires.
Study Type
Observational
Enrollment (Actual)
49
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Palo Alto, California, United States, 94303
- Stanford Eye Laser Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
Adults over the age of 21 with healthy eyes and nearsightedness, farsightedness and/or astigmatism
Description
Inclusion Criteria:
- Are aged 21 years or older.
- Have the ability to give informed consent.
- Speak and read English fluently.
- Have not previously had any form of refractive surgery, including prior LASIK or cataract surgery.
- May benefit from increased spectacle independence.
- Have been determined to be a good candidate for the LASIK procedure based on the investigator's assessment of medical and ophthalmic health, general cognitive function, and physical and social limitations.
- Have a treatment target of bilateral emmetropia.
- Express willingness and potential ability to return for all follow-up examinations through the 12-month follow-up exam under the care of the treating investigator.
- Are not enrolled in any other research study.
Exclusion Criteria:
- Subjects under the age of 21.
- Patients with excessively thin corneas.
- Patients with topographic evidence of keratoconus.
- Patients with ectactic eye disorders.
- Patients with autoimmune diseases.
- Patients who are pregnant or nursing.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Quality of Vision after LASIK surgery
Questionnaire
|
Patient questionnaire
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of Vision and Quality of Life Questionnaires after LASIK Surgery
Time Frame: 12 months
|
Patients will complete questionnaires preoperatively and postoperatively at month twelve.
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Edward E Manche, MD, Stanford University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2014
Primary Completion (Actual)
February 1, 2023
Study Completion (Actual)
February 1, 2023
Study Registration Dates
First Submitted
June 6, 2014
First Submitted That Met QC Criteria
June 10, 2014
First Posted (Estimated)
June 11, 2014
Study Record Updates
Last Update Posted (Actual)
March 19, 2024
Last Update Submitted That Met QC Criteria
March 17, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 30301
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Astigmatism
-
Bausch & Lomb IncorporatedNot yet recruiting
-
London Vision ClinicOptana GmbHActive, not recruitingCorneal AstigmatismUnited Kingdom
-
Eye Hospital Pristina KosovoActive, not recruiting
-
Yonsei UniversityUnknownMyopic AstigmatismKorea, Republic of
-
Abbott Medical OpticsCompletedRefractive AstigmatismAustria
-
Ohio State UniversityAlcon ResearchCompletedAstigmatism BilateralUnited States
-
Ohio State UniversityCompletedAstigmatism BilateralUnited States
-
CooperVision, Inc.Completed
-
Cairo UniversityUnknown
Clinical Trials on Patient Quality of Life andVision after LASIK Surgery
-
Ramsay Générale de SantéEuropean Clinical Trial Experts Network; Private Hospital DijonRecruitingVenous Allogeneic Transplant | Occlusive Peripheral Arterial DiseaseFrance
-
Mansoura University HospitalRecruiting
-
Hôpital Edouard HerriotUnknown
-
West China HospitalNot yet recruitingEnd Stage Renal Failure | Secondary Hyperparathyroidism Due to Renal Causes
-
Ohio State University Comprehensive Cancer CenterCompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
University of Texas Southwestern Medical CenterWithdrawn
-
Centre Hospitalier Universitaire DijonCompletedIdiopathic Pulmonary Fibrosis | Patient-caregiver DyadsFrance
-
Chunling JiangNot yet recruitingSecondary Hyperparathyroidism | End Stage Renal Failure
-
Assistance Publique Hopitaux De MarseilleCompletedVery Preterm Children With Dysexecutive DisordersFrance